newsfilter
← Latest News
GlobeNewswire·

Codexis Enters into $60 Million Term Loan Facility with Trinity Capital

  • Codexis, Inc. entered a $60 million senior secured term loan agreement with Trinity Capital Inc.
  • Proceeds from the first tranche were used to retire existing debt held by Innovatus Life Sciences Lending Fund I.
  • Post-closing, Codexis has $42.5 million in outstanding debt.
  • The new loan includes 48 months of interest-only payments followed by a 12-month amortization period starting in November 2030.
  • The refinancing aims to enhance financial flexibility for growth initiatives in the siRNA therapeutic sector.
  • Key objectives include industrializing the ECO Synthesis platform and advancing GMP manufacturing for oligonucleotide synthesis.
  • The loan terms are detailed in a security agreement to be filed with the SEC as an exhibit to Form 8-K.
Company
Codexis, Inc.
Keywords
Nasdaq:CDXS, Codexis, Inc.